Zura Bio Ltd (ZURA)
Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its key product candidates include ZB-168, an anti-IL7Rα inhibitor engineered to address conditions influenced by the IL7 and TSLP biological pathways. The company is also advancing Torudokimab, a monoclonal antibody that neutralizes IL-33, which is currently in Phase 2 clinical development.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
Zura Bio Limited
Zura Bio Ltd (ZURA) dilution facts from SEC filings
Snapshot as of Sep 30, 2026, built from 43 SEC filings.
- Warrants outstanding
- 5 warrant series recorded as outstanding
Check another stock for dilution
Facts as recorded in the company's SEC filings. The full snapshot, with instrument terms, share counts and history, is part of Signal8 Pro.